• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased Risk of Venous Thromboembolic Events With Corticosteroid Versus Biologic Therapy for Inflammatory Bowel Disease.

作者信息

Murthy Sanjay K, Nguyen Geoffrey C

机构信息

The Ottawa Hospital IBD Centre, University of Ottawa, Ottawa, Ontario, Canada.

Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, Canada.

出版信息

Clin Gastroenterol Hepatol. 2016 Jan;14(1):166-7. doi: 10.1016/j.cgh.2015.04.022. Epub 2015 Apr 27.

DOI:10.1016/j.cgh.2015.04.022
PMID:25929541
Abstract
摘要

相似文献

1
Increased Risk of Venous Thromboembolic Events With Corticosteroid Versus Biologic Therapy for Inflammatory Bowel Disease.与生物制剂治疗炎症性肠病相比，使用皮质类固醇治疗炎症性肠病会增加静脉血栓栓塞事件的风险。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):166-7. doi: 10.1016/j.cgh.2015.04.022. Epub 2015 Apr 27.
2
Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease.与生物治疗相比，皮质类固醇治疗炎症性肠病会增加静脉血栓栓塞事件的风险。
Clin Gastroenterol Hepatol. 2015 Feb;13(2):316-21. doi: 10.1016/j.cgh.2014.07.017. Epub 2014 Jul 17.
3
Reply.
Clin Gastroenterol Hepatol. 2016 Jan;14(1):167-8. doi: 10.1016/j.cgh.2015.09.012. Epub 2015 Sep 24.
4
Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.抗肿瘤坏死因子-α治疗与炎症性肠病住院患者血栓栓塞事件风险降低相关。
J Clin Gastroenterol. 2016 Aug;50(7):578-83. doi: 10.1097/MCG.0000000000000408.
5
Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 2019 Sep;50(6):712-713. doi: 10.1111/apt.15411.
6
Letter: previous exposure to corticosteroids increases the risk of post-discharge venous thromboembolic events in patients with inflammatory bowel disease-author's reply.
Aliment Pharmacol Ther. 2019 Sep;50(6):714-715. doi: 10.1111/apt.15457.
7
Risks and benefits of biologic therapy for inflammatory bowel diseases.生物疗法治疗炎症性肠病的风险与益处。
Gut. 2007 May;56(5):725-32. doi: 10.1136/gut.2006.103564.
8
Steroids and the Risk of Venous Thromboembolic Events in Inflammatory Bowel Disease.类固醇与炎症性肠病患者静脉血栓栓塞事件的风险
J Crohns Colitis. 2018 Apr 27;12(5):627. doi: 10.1093/ecco-jcc/jjx183.
9
Venous thromboembolism in inflammatory bowel disease: an epidemiological review.炎症性肠病中的静脉血栓栓塞症：一项流行病学综述。
Am J Gastroenterol. 2011 Apr;106(4):713-8. doi: 10.1038/ajg.2011.53. Epub 2011 Mar 15.
10
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.炎症性肠病活动期和缓解期的静脉血栓栓塞症：一项队列研究。
Lancet. 2010 Feb 20;375(9715):657-63. doi: 10.1016/S0140-6736(09)61963-2. Epub 2010 Feb 8.

引用本文的文献

1
Tea Tree Oil Terpinen-4-ol Protects Gut Barrier Integrity by Upregulation of Tight Junction Proteins the ERK1/2-Signaling Pathway.茶树油萜品-4-醇通过上调紧密连接蛋白和ERK1/2信号通路来保护肠道屏障完整性。
Front Nutr. 2022 Jan 27;8:805612. doi: 10.3389/fnut.2021.805612. eCollection 2021.